SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-027197
Filing Date
2021-05-13
Accepted
2021-05-13 07:00:41
Documents
14
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcrr-8k_20210513.htm   iXBRL 8-K 38845
2 EX-99.1 tcrr-ex991_6.htm EX-99.1 301086
3 GRAPHIC g0r5axvuuxvz000001.jpg GRAPHIC 19431
  Complete submission text file 0001564590-21-027197.txt   517147

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20210513.xsd EX-101.SCH 5760
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20210513_lab.xml EX-101.LAB 20218
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20210513_pre.xml EX-101.PRE 12072
7 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-8k_20210513_htm.xml XML 3659
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 21917141
SIC: 2836 Biological Products, (No Diagnostic Substances)